Andelyn Biosciences Selected as Viral Vector Manufacturing Partner for the Foundation for the National Institutes of Health (FNIH) Accelerating Medicines Partnership® (AMP®) Bespoke Gene Therapy Consortium (BGTC)

This post was originally published on this siteCOLUMBUS, Ohio, Feb. 28, 2024 /PRNewswire/ — Andelyn Biosciences, Inc., a pioneering and patient-focused cell and gene therapy Contract Development and Manufacturing Organization (CDMO), has been selected to manufacture adeno-associated vectors (AAV) therapies in its suspension platform…

Continue Reading

CROWN SIGNS RENEWABLE ENERGY DEAL SIGNIFICANTLY EXPANDING COVERAGE OF ITS ELECTRICITY CONSUMPTION IN EUROPE

This post was originally published on this siteRenewable energy (RE) adoption drives Crown’s Twentyby30™ targets forward; new Virtual Power Purchase Agreement (VPPA) shows continued commitment to sustainability TAMPA, Fla., Feb. 28, 2024 /PRNewswire/ — Crown Holdings, Inc. (NYSE: CCK) has entered a 15-year Virtual Power Purchase…

Continue Reading